Precision Prostate Cancer Management

0

1. Prostate cancer shows significant heterogeneity requiring stratification.

2. Identification of gene fusions aids in classifying tumors.

3. Non-ETS fusions like SLC45A3-BRAF have oncogenic potential.

4. KLK4-KLKP1 fusion is detectable in urine, aiding non-invasive monitoring.

5. Comprehensive profiling is critical for personalized therapy.

6. Future research will focus on transcriptomic analyses of treatment-resistant tumors.

7. Personalized approaches could guide targeted therapies for prostate cancer patients.